Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study

AM. Polhemus, J. Novák, J. Ferrao, S. Simblett, M. Radaelli, P. Locatelli, F. Matcham, M. Kerz, J. Weyer, P. Burke, V. Huang, MF. Dockendorf, G. Temesi, T. Wykes, G. Comi, I. Myin-Germeys, A. Folarin, R. Dobson, NV. Manyakov, VA. Narayan, M. Hotopf

. 2020 ; 8 (5) : e16043. [pub] 20200507

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012605

Grantová podpora
171 Alzheimer's Society - United Kingdom
G0901434 Medical Research Council - United Kingdom
MC_PC_17214 Medical Research Council - United Kingdom

BACKGROUND: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, "off-the-shelf" devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. OBJECTIVE: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. METHODS: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. RESULTS: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. CONCLUSIONS: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012605
003      
CZ-PrNML
005      
20210713152743.0
007      
ta
008      
210420s2020 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.2196/16043 $2 doi
035    __
$a (PubMed)32379055
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Polhemus, Ashley Marie $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic ; Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland
245    10
$a Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study / $c AM. Polhemus, J. Novák, J. Ferrao, S. Simblett, M. Radaelli, P. Locatelli, F. Matcham, M. Kerz, J. Weyer, P. Burke, V. Huang, MF. Dockendorf, G. Temesi, T. Wykes, G. Comi, I. Myin-Germeys, A. Folarin, R. Dobson, NV. Manyakov, VA. Narayan, M. Hotopf
520    9_
$a BACKGROUND: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, "off-the-shelf" devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. OBJECTIVE: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. METHODS: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. RESULTS: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. CONCLUSIONS: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.
650    _2
$a zdravotnický personál $7 D006282
650    _2
$a lidé $7 D006801
650    _2
$a technologie $7 D013672
650    12
$a telemedicína $7 D017216
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Novák, Jan $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic ; Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Ferrao, Jose $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic
700    1_
$a Simblett, Sara $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
700    1_
$a Radaelli, Marta $u Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy
700    1_
$a Locatelli, Patrick $u Department of Engineering and Applied Science, University of Bergamo, Bergamo, Italy
700    1_
$a Matcham, Faith $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom ; National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
700    1_
$a Kerz, Maximilian $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
700    1_
$a Weyer, Janice $u Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom
700    1_
$a Burke, Patrick $u Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom
700    1_
$a Huang, Vincy $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Singapore, Singapore
700    1_
$a Dockendorf, Marissa Fallon $u Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co, Inc, Kenilworth, NJ, United States
700    1_
$a Temesi, Gergely $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic
700    1_
$a Wykes, Til $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
700    1_
$a Comi, Giancarlo $u Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy
700    1_
$a Myin-Germeys, Inez $u Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium
700    1_
$a Folarin, Amos $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
700    1_
$a Dobson, Richard $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
700    1_
$a Manyakov, Nikolay V $u Janssen Pharmaceutica NV, Beerse, Belgium
700    1_
$a Narayan, Vaibhav A $u Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States
700    1_
$a Hotopf, Matthew $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
773    0_
$w MED00198720 $t JMIR mHealth and uHealth $x 2291-5222 $g Roč. 8, č. 5 (2020), s. e16043
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32379055 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210713152740 $b ABA008
999    __
$a ok $b bmc $g 1650882 $s 1132984
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 8 $c 5 $d e16043 $e 20200507 $i 2291-5222 $m JMIR mHealth and uHealth $n JMIR Mhealth Uhealth $x MED00198720
GRA    __
$a 171 $p Alzheimer's Society $2 United Kingdom
GRA    __
$a G0901434 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_PC_17214 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...